Discover the latest developments in Organ-on-a-Chip
Posted: 18 February 2016 | SELECTBIO | No comments yet
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 – 6 April in Cambridge, UK…
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 – 6 April in Cambridge, UK.
This inaugural conference will explore this emerging field wherein microfluidics-based approaches are being utilised to assemble clusters of cells in a physiologically-relevant architecture. These organs-on-chips can be utilised for functional studies ex vivo such as toxicity screening wherein a proper spatial cellular organization is key to manifest functionality.
Organ-on-a-Chip Europe will feature keynote presentations from:
- Lars Sundstrom, Professor of Practice in Translational Medicine, Elizabeth Blackwell Institute for Health Research, Bristol University
- David Hughes, Chief Technical Officer, CN Bio Innovations Ltd
- David Jones, Senior Scientific Advisor, Medicines and Healthcare Products Regulatory Agency
- Reyk Horland, Vice President, TissUse GmbH
Presentations from academics and industry participants will highlight the emerging trends in this field as well as providing a path forward for technology and applications development. Agenda topics include:
- Brain/Neuron-on-a-Chip
- Challenges in the Development of Organs-on-Chips
- Construction of Organs-on-chips utilizing Microfluidics-based Approaches
- Disease-on-a-Chip
- Gut-on-a-Chip
- Heart-on-a-Chip
- Liver-on-a-Chip for Toxicity Screening/Toxicology Studies
- Lung-on-a-Chip
- Public and Private Efforts in the Development of Organs-on-Chips/Body-on-a-Chip
The full agenda can be viewed on SELECTBIO.com
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
As well as benefiting from a 3for2 offer on all passes, registered delegates will have access to an additional track, Stem Cells in Drug Discovery, where there will be even more talks, attendees and discussions.
SELECTBIO welcomes poster presentations as a means to disseminate the most cutting-edge work by researchers in this field.
Related topics
Microfluidic Technology, Organ-on-a-Chip
